Long-Term Follow-up Analysis of Progression-Free and Overall Survival in Newly Diagnosed Multiple Myeloma Patients from the GMMG Myeloma Registry Following the Randomized Phase III GMMG-HD6 Trial

被引：0

作者：

Keller, Anne-Valerie ^{[1
]}

Hajiyianni, Marina ^{[2
]}

Kurre, Eileen ^{[1
]}

Mai, Elias Karl ^{[1
,2
]}

Bertsch, Uta ^{[1
,2
,3
]}

Benner, Axel ^{[4
]}

Luntz, Steffen ^{[5
]}

Raab, Marc-Steffen ^{[1
,2
]}

Besemer, Britta ^{[6
]}

Michel, Christian Sebastian ^{[7
]}

Schroers, Roland ^{[8
]}

Fenk, Roland ^{[9
]}

Salwender, Hans ^{[10
]}

Blau, Igor Wolfgang ^{[11
]}

Haenel, Mathias ^{[2
,12
]}

Mann, Christoph ^{[13
]}

Goldschmidt, Hartmut ^{[1
,2
,3
]}

机构：

[1] Heidelberg Univ Hosp, Internal Med Hematol Oncol & Rheumatol 5, GMMG Study Grp, Heidelberg, Germany

[2] Univ Hosp Heidelberg, Heidelberg Myeloma Ctr, Dept Med 5, Heidelberg, Germany

[3] Natl Ctr Tumor Dis Heidelberg, Heidelberg, Germany

[4] German Canc Res Ctr, Div Biostat, Heidelberg, Germany

[5] Coordinat Ctr Clin Trials KKS, Heidelberg, Germany

[6] Univ Hosp Tubingen, Dept Internal Med 2, Tubingen, Germany

[7] Univ Hosp Mainz, Dept Internal Med 3, Mainz, Germany

[8] Univ Hosp Bochum, Med Clin, Bochum, Germany

[9] Univ Hosp Dusseldorf, Dept Haematol Oncol & Clin Immunol, Dusseldorf, Germany

[10] Asklepios Hosp Hamburg Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany

[11] Med Klin M S Hamatol Onkol & Tumorimmunol, Berlin, Germany

[12] Klinikum Chemnitz, Dept Internal Med 3, Chemnitz, Germany

[13] Philipps Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-194188

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：5140 / 5142

页数：3

共 50 条

[21] Salvage Autologous Transplant and Lenalidomide Maintenance Versus Continuous Lenalidomide/Dexamethasone for Relapsed Multiple Myeloma: Long Term Follow up Results of the Randomized GMMG Phase III Multicenter Trial Relapse
Baertsch, Marc-Andrea
Schlenzka, Jana
Hielscher, Thomas
Raab, Marc S.
Sauer, Sandra
Merz, Maximilian
Mai, Elias K.
Mueller-Tidow, Carsten
Luntz, Steffen
Jauch, Anna
Brossart, Peter
Goerner, Martin
Klein, Stefan
Glass, Bertram
Reimer, Peter
Graeven, Ullrich
Fenk, Roland
Haenel, Mathias
von Metzler, Ivana
Hans, Lindemann W.
Scheid, Christof
Nogai, Axel
Salwender, Hans
Noppeney, Richard
Besemer, Britta
Weisel, Katja
Goldschmidt, Hartmut
BLOOD, 2023, 142
[22] Bortezomib during induction and maintenance before and after autologous transplantation improves overall survival in patients with renal impairment: subgroup analysis from the HOVON-65/GMMG-HD4 randomized trial for newly diagnosed multiple myeloma
Scheid, C.
Sonneveld, P.
Schmidt-Wolf, I.
van der Holt, B.
Hielscher, T.
el Jarari, L.
Bertsch, U.
Salwender, H.
Zweegman, S.
Haenel, M.
Vellenga, E.
Schubert, J.
Blau, I. W.
Jie, A.
van de Velde, H.
Peter, N.
Schaafsma, M.
Lindemann, W.
Kersten, M.
Duehrsen, U.
Delforge, M.
Weisel, K.
Croockewit, S.
Martin, H.
Wittebol, S.
Schouten, H.
van Marwijk-Kooy, M.
Wijermans, P.
Lokhorst, H.
Goldschmidt, H.
BONE MARROW TRANSPLANTATION, 2011, 46 : S37 - S38
[23] Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/GMMG-HD4 Trial (vol 30, pg 2946, 2012)
Sonneveld, P.
Schmidt-Wolf, I. G. H.
van der Hold, B.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (29) : 3654 - 3654
[24] Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance
Kumar, Shaji K.
Berdeja, Jesus G.
Niesvizky, Ruben
Lonial, Sagar
Laubach, Jacob P.
Hamadani, Mehdi
Stewart, A. Keith
Hari, Parameswaran
Roy, Vivek
Vescio, Robert
Kaufman, Jonathan L.
Berg, Deborah
Liao, Eileen
Rajkumar, S. Vincent
Richardson, Paul G.
LEUKEMIA, 2019, 33 (07) : 1736 - 1746
[25] Effect of thrombotic events on overall survival in patients with newly diagnosed myeloma: Analysis from a randomized phase III trial of thalidomide plus dexamethasone versus dexamethasone in newly diagnosed multiple myeloma (E1A00)
Kumar, Shaji
Zhang, Lijun
Greipp, Philip R.
Rajkumar, S. Vincent
BLOOD, 2007, 110 (11) : 803A - 803A
[26] Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance
Shaji K. Kumar
Jesus G. Berdeja
Ruben Niesvizky
Sagar Lonial
Jacob P. Laubach
Mehdi Hamadani
A. Keith Stewart
Parameswaran Hari
Vivek Roy
Robert Vescio
Jonathan L. Kaufman
Deborah Berg
Eileen Liao
S. Vincent Rajkumar
Paul G. Richardson
Leukemia, 2019, 33 : 1736 - 1746
[27] Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial
H Goldschmidt
H M Lokhorst
E K Mai
B van der Holt
I W Blau
S Zweegman
K C Weisel
E Vellenga
M Pfreundschuh
M J Kersten
C Scheid
S Croockewit
R Raymakers
D Hose
A Potamianou
A Jauch
J Hillengass
M Stevens-Kroef
M S Raab
A Broijl
H W Lindemann
G M J Bos
P Brossart
M van Marwijk Kooy
P Ypma
U Duehrsen
R M Schaafsma
U Bertsch
T Hielscher
Le Jarari
H J Salwender
P Sonneveld
Leukemia, 2018, 32 : 383 - 390
[28] Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
Broyl, Annemiek
Corthals, Sophie L.
Jongen, Joost L. M.
van der Holt, Bronno
Kuiper, Rowan
de Knegt, Yvonne
van Duin, Mark
el Jarari, Laila
Bertsch, Uta
Lokhorst, Henk M.
Durie, Brian G.
Goldschmidt, Hartmut
Sonneveld, Pieter
LANCET ONCOLOGY, 2010, 11 (11): : 1057 - 1065
[29] Bortezomib With High-dose Melphalan Conditioning Regimen in Newly Diagnosed Multiple Myeloma Patients: Long-term Follow-up
Nishiyama, Risa
Kagoo, Toshiya
Ueno, Hironori
Yokoyama, Akihiro
IN VIVO, 2025, 39 (01): : 340 - 345
[30] Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
Gay, Francesca
Larocca, Alessandra
Wijermans, Pierre
Cavallo, Federica
Rossi, Davide
Schaafsma, Ron
Genuardi, Mariella
Romano, Alessandra
Liberati, Anna Marina
Siniscalchi, Agostina
Petrucci, Maria T.
Nozzoli, Chiara
Patriarca, Francesca
Offidani, Massimo
Ria, Roberto
Omede, Paola
Bruno, Benedetto
Passera, Roberto
Musto, Pellegrino
Boccadoro, Mario
Sonneveld, Pieter
Palumbo, Antonio
BLOOD, 2011, 117 (11) : 3025 - 3031

← 1 2 3 4 5 →